Views - Page 13 - Lumanity

Is Novartis’ RNA Therapeutic Inclisiran Poised to Displace PCSK9 Antibodies and Become the Next Blockbuster Lipid-Lowering Drug

In the last several years, RNA-targeted platforms yielded FDA/EMA approved therapies for ultra-rare metabolic and neurodegenerative diseases that address...

View Mar 24, 2020

Using Genomics to Track the Global Spread of COVID19

View Mar 23, 2020

Innovation in a Buyer’s Market: Standing Out in an Increasingly Crowded and Diversified Cancer Treatment Algorithm

View Feb 18, 2020

Oncology 2020, the Coming Decade’s Visionary Advances – Part III

View Feb 16, 2020

Hit the Road Running, an Introduction to Publications

View Feb 12, 2020

FDA Antimicrobial Drugs Advisory Committee Meeting (AMDAC) Recommends Approval of FETROJA (cefiderocol lyophilized powder)

On October 16, 2019, the Antimicrobial Drugs Advisory Committee (AMDAC) reviewed the New Drug Application (NDA) 209445 for cefiderocol lyophilized powder (Shionogi Inc.) for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis due to gram-negative bacteria in patients with limited or no alternative treatment options.

View Feb 7, 2020

CD19 and BCMA – “What if This Is As Good as It Gets?”

View Feb 5, 2020

A Tale Of Two Pipelines

View Jan 28, 2020

How to Approach SEO in Healthcare and Pharma

View Jan 14, 2020

‘Allo There!’ – Accommodation of a Less-Than-Stellar TPP for Allo Cell Therapy in the Oncology Landscape

View Jan 8, 2020

Part III: Bringing a Winning Idea to Market

Happy new year colleagues and friends! It is hard to believe this month marks the one year anniversary of our inaugural Health Action Community (HAC) event, focused on addressing unmet needs in metastatic breast cancer (MBC).

View Jan 6, 2020

A Month of Awareness and Thanks

View Nov 19, 2019

Let’s Recognize the Advances in Lung Cancer this November

View Nov 4, 2019

Rare Diseases: Why Lexicon Matters

View Aug 26, 2019

ASCO Shifts Gears and Puts Patients First

View Jun 6, 2019

Conquering the Challenges of Change

There is evidence of profound transformation across every facet of healthcare from drug discovery, to delivery, access, and everything in between. Already a complex system, the pace of change continues to increase, compounding the ability to keep up. At the center of all this change is people.

View Jun 1, 2019